Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.


CSE:GHG - Post by User

Bullboard Posts
Comment by hempsteron Mar 16, 2018 2:36pm
44 Views
Post# 27729686

RE:RE:RE:RE:RE:RE:another 1.1 million to chew through

RE:RE:RE:RE:RE:RE:another 1.1 million to chew throughyou are forgetting that most weed stocks are firstly still penny stocks and even the big ones like ACB , Canopy and whoeverelse are still very far away from being mainstream investments, and secondly retail investors who invest in such stocks have usually a higher risk tolerance and dont put a lot of money in these stock. additionally, institutional investors do hardly invest in such small stocks, they are the minority of shareholders - all in all id say that the performance of penny/weed stocks is hardly correlated to the overall market sentiment, news releases and shareholder communication play a much bigger role and are much bigger market movers. plus in regard to cannabis stocks, legal progress/ news regarding legalisation and hemp regulations are also major market movers - the whole run of the weed stocks last autumn was mostly caused by news regarding legalisation.


if fear really had played a role in the recent performance of weed/penny stocks we would have seen much more volume in terms of selling (and also buying!) and in general much more volatility, but since the decline since january was pretty steady and the trading volume so low, its pretty sure to say that it was mostly caused by impatient share holders who expected GHG and other similar stocks to reach 400$ by mid february and a few short sellers and the lack of news which helped to boost the impatience of some shareholders.
Bullboard Posts